About Novelion

Novelion Therapeutics Inc. (“Novelion"), headquartered in Vancouver, British Columbia, owns a minority equity interest in Amryt Pharma plc, a biopharmaceutical company based in Dublin, Ireland, focused on rare and orphan diseases. Effective January 16, 2020 at 5:00 p.m. Pacific Time, Novelion commenced implementation of a shareholder-approved plan of liquidation, with Alvarez & Marsal Canada Inc. acting as Liquidator under the Business Corporations Act (British Columbia). Visit www.alvarezandmarsal.com/novelion for additional information on Novelion and the liquidation.

Breadcrumb

Investors // Investors //